Michael R Graham
Overview
Explore the profile of Michael R Graham including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Graham M, Baker J, Davies B
Diabetes Metab Syndr Obes
. 2015 Sep;
8:455-60.
PMID: 26396538
No abstract available.
2.
Graham M, Davies B, Baker J
J Sports Sci Med
. 2013 Nov;
6(CSSI-2):62-4.
PMID: 24198706
A 33 year old male karate practitioner presented himself for a full-contact national karate competition. This individual competed for approximately 2 minutes and received a kick to the head. He...
3.
Graham M, Ryan P, Baker J, Davies B, Thomas N, Cooper S, et al.
Drug Test Anal
. 2010 Apr;
1(3):135-42.
PMID: 20355187
The current drastic escalation in obesity may be contributing to the exponential rise in drugs used for image enhancement. Drugs such as anabolic-androgenic steroids (AAS) are perceived as a viable...
4.
Graham M, Evans P, Thomas N, Davies B, Baker J
Am J Cardiovasc Drugs
. 2009 Nov;
9(6):371-81.
PMID: 19929035
Arterial endothelial dysfunction is an early event in the pathogenesis of atherosclerosis and predisposes individuals to the deposition of unstable atherosclerotic plaques. It can also lead to increased arterial stiffness,...
5.
Graham M, Baker J, Evans P, Hullin D, Thomas N, Davies B
Growth Horm IGF Res
. 2009 Jun;
19(4):300-7.
PMID: 19539505
Athletes have enjoyed almost a thirty year amnesty of rhGH abuse, which they consider has contributed to the winning of medals and the breaking of world records. Such a reprieve...
6.
Graham M, Evans P, Davies B, Baker J
Vasc Health Risk Manag
. 2009 Apr;
4(6):1361-71.
PMID: 19337549
Blood pressure (BP) measurements provide information regarding risk factors associated with cardiovascular disease, but only in a specific artery. Arterial stiffness (AS) can be determined by measurement of arterial pulse...
7.
Graham M, Evans P, Davies B, Baker J
Ther Clin Risk Manag
. 2008 Oct;
4(3):587-97.
PMID: 18827854
The nontherapeutic use of prescription medicines by individuals involved in sport is increasing. Anabolic-androgenic steroids (AAS) are the most widely abused drug. Much of our knowledge of the psychological and...
8.
Graham M, Baker J, Evans P, Kicman A, Cowan D, Hullin D, et al.
Horm Res
. 2008 May;
69(6):343-54.
PMID: 18504393
Background/aims: Recombinant human growth hormone (rhGH) as opposed to cadaver pituitary GH is misused for physical improvement. Six days' rhGH administration, in abstinent anabolic-androgenic steroid dependents, was compared with controls....
9.
Graham M, Davies B, Grace F, Kicman A, Baker J
Sports Med
. 2008 May;
38(6):505-25.
PMID: 18489196
Anabolic-androgenic steroids (AAS) were the first identified doping agents that have ergogenic effects and are being used to increase muscle mass and strength in adult males. Consequently, athletes are still...
10.
Graham M, Baker J, Evans P, Kicman A, Cowan D, Hullin D, et al.
Growth Horm IGF Res
. 2007 May;
17(4):328-35.
PMID: 17512232
Objectives: To determine whether 6 days recombinant human growth hormone (rhGH) administration, in an abstinent anabolic-androgenic steroid (AAS) using group had any respiratory, endurance exercise and biochemical effects compared with...